Literature DB >> 20098451

Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome.

Montserrat Ayala-Ramirez1, Glenda G Callender, Michael E Kupferman, Thereasa A Rich, Hubert H Chuang, Jonathan Trent, Nancy D Perrier, Mahmoud Goodarzi, Camilo Jimenez.   

Abstract

BACKGROUND: A 33-year-old man was referred to a specialist center with a left neck mass and hypertension. The patient underwent surgery, which confirmed a malignant neck paraganglioma with metastasis to a cervical lymph node. He had no family history of carotid body tumors or pheochromocytoma. INVESTIGATIONS: Measurements of plasma free metanephrines and chromogranin A; radiographic evaluations with CT, (18)F-fluorodeoxyglucose PET and (123)I-labeled metaiodobenzylguanidine scan; gene analysis for mutations in the SDHD and the KIT gene. DIAGNOSIS: Paraganglioma syndrome type 1 in a patient with a paraganglioma, bilateral pheochromocytomas and a gastrointestinal stromal tumor with a somatic Asp579del KIT mutation. MANAGEMENT: The patient underwent surgical excision of all tumors after adequate preparation with alpha and beta blockers. Blood pressure normalized after surgery. The patient is examined regularly with biochemical and radiographic studies, and his follow-up is expected to last throughout life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20098451     DOI: 10.1038/nrendo.2009.250

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  28 in total

1.  Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene.

Authors:  B Havekes; E P M Corssmit; J C Jansen; A G L van der Mey; A H J T Vriends; J A Romijn
Journal:  J Clin Endocrinol Metab       Date:  2007-01-16       Impact factor: 5.958

2.  Maternal transmission of symptomatic disease with SDHD mutation: fact or fiction?

Authors:  Hartmut P H Neumann; Zoran Erlic
Journal:  J Clin Endocrinol Metab       Date:  2008-05       Impact factor: 5.958

Review 3.  Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?

Authors:  Camilo Jiménez; Gilbert Cote; Andrew Arnold; Robert F Gagel
Journal:  J Clin Endocrinol Metab       Date:  2006-05-30       Impact factor: 5.958

Review 4.  Imaging of pheochromocytoma and paraganglioma.

Authors:  I Brink; S Hoegerle; J Klisch; T A Bley
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

5.  Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.

Authors:  Diana E Benn; Anne-Paule Gimenez-Roqueplo; Jennifer R Reilly; Jérôme Bertherat; John Burgess; Karen Byth; Michael Croxson; Patricia L M Dahia; Marianne Elston; Oliver Gimm; David Henley; Philippe Herman; Victoria Murday; Patricia Niccoli-Sire; Janice L Pasieka; Vincent Rohmer; Kathy Tucker; Xavier Jeunemaitre; Deborah J Marsh; Pierre-François Plouin; Bruce G Robinson
Journal:  J Clin Endocrinol Metab       Date:  2005-11-29       Impact factor: 5.958

6.  Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.

Authors:  Karel Pacak; Graeme Eisenhofer; Håkan Ahlman; Stefan R Bornstein; Anne-Paule Gimenez-Roqueplo; Ashley B Grossman; Noriko Kimura; Massimo Mannelli; Anne Marie McNicol; Arthur S Tischler
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-02

7.  The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.

Authors:  A P Gimenez-Roqueplo; J Favier; P Rustin; J J Mourad; P F Plouin; P Corvol; A Rötig; X Jeunemaitre
Journal:  Am J Hum Genet       Date:  2001-10-16       Impact factor: 11.025

8.  SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.

Authors:  Huai-Xiang Hao; Oleh Khalimonchuk; Margit Schraders; Noah Dephoure; Jean-Pierre Bayley; Henricus Kunst; Peter Devilee; Cor W R J Cremers; Joshua D Schiffman; Brandon G Bentz; Steven P Gygi; Dennis R Winge; Hannie Kremer; Jared Rutter
Journal:  Science       Date:  2009-07-23       Impact factor: 47.728

Review 9.  Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging.

Authors:  B Havekes; E W Lai; E P M Corssmit; J A Romijn; H J L M Timmers; K Pacak
Journal:  Q J Nucl Med Mol Imaging       Date:  2008-12       Impact factor: 2.346

Review 10.  Malignant pheochromocytomas and paragangliomas: molecular signaling pathways and emerging therapies.

Authors:  L Santarpia; M A Habra; C Jiménez
Journal:  Horm Metab Res       Date:  2009-04-02       Impact factor: 2.936

View more
  8 in total

1.  Carney Stratakis syndrome in a patient with SDHD mutation.

Authors:  Carmen Tenorio Jiménez; Louise Izatt; Fuju Chang; Mufaddal T Moonim; Paul V Carroll; Barbara M McGowan
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

Review 2.  Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.

Authors:  Victoria L Martucci; Karel Pacak
Journal:  Curr Probl Cancer       Date:  2014-01-15       Impact factor: 3.187

3.  Novel germline SDHD mutation: diagnosis and implications to the patient.

Authors:  Jeena Varghese; Montserrat Ayala-Ramirez; Thereasa Rich; Eric Rohren; Priya Rao; Camilo Jimenez
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

Review 4.  Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma.

Authors:  Camilo Jimenez; Eric Rohren; Mouhammed Amir Habra; Thereasa Rich; Paola Jimenez; Montserrat Ayala-Ramirez; Eric Baudin
Journal:  Curr Oncol Rep       Date:  2013-08       Impact factor: 5.075

Review 5.  Syndromic gastrointestinal stromal tumors.

Authors:  Riccardo Ricci
Journal:  Hered Cancer Clin Pract       Date:  2016-07-19       Impact factor: 2.857

Review 6.  Succinate dehydrogenase deficiency in a PDGFRA mutated GIST.

Authors:  Martin G Belinsky; Kathy Q Cai; Yan Zhou; Biao Luo; Jianming Pei; Lori Rink; Margaret von Mehren
Journal:  BMC Cancer       Date:  2017-08-02       Impact factor: 4.430

7.  Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene.

Authors:  Valentina Indio; Annalisa Astolfi; Giuseppe Tarantino; Milena Urbini; Janice Patterson; Margherita Nannini; Maristella Saponara; Lidia Gatto; Donatella Santini; Italo F do Valle; Gastone Castellani; Daniel Remondini; Michelangelo Fiorentino; Margaret von Mehren; Giovanni Brandi; Guido Biasco; Michael C Heinrich; Maria Aabbondanza Pantaleo
Journal:  Int J Mol Sci       Date:  2018-03-04       Impact factor: 5.923

8.  KIT Mutation in Gastric Gastrointestinal Stromal Tumor in a Patient With Familial Paraganglioma Syndrome Type 4.

Authors:  Robyn L Houlden; Cassandra L A Hawco
Journal:  AACE Clin Case Rep       Date:  2021-01-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.